Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

As of 18 Aug 2026, Lupin Ltd. closed at ₹2,259.20, marking a modest gain of 1.08% from the previous close of ₹2,235.00. The stock traded within a range of ₹2,219.75 to ₹2,265.50 during the day, remaining below its 52-week high of ₹2,530.00 but comfortably above the 52-week low of ₹1,881.80. This price action reflects a cautious optimism among investors, supported by a shift in the technical trend from sideways to mildly bullish.

Comparatively, Lupin’s recent returns have outperformed the broader Sensex benchmark over multiple time horizons. Year-to-date, Lupin has gained 6.97%, while the Sensex has declined by 8.79%. Over one year, Lupin’s return stands at 15.27%, significantly ahead of the Sensex’s negative 3.56%. Even over three and five years, Lupin has delivered robust returns of 107.04% and 131.93% respectively, dwarfing the Sensex’s 19.30% and 39.32% gains. This long-term outperformance underscores the company’s resilience and growth potential within its sector.

MACD and Momentum Indicators Signal Divergence

The Moving Average Convergence Divergence (MACD) indicator presents a complex scenario for Lupin. On a weekly basis, the MACD remains mildly bearish, suggesting some short-term selling pressure or consolidation. However, the monthly MACD is bullish, indicating that the longer-term momentum remains positive. This divergence implies that while short-term traders may face some headwinds, the broader trend favours accumulation and upward price movement.

Similarly, the Know Sure Thing (KST) indicator is mildly bearish on both weekly and monthly charts, reinforcing the notion of short-term caution. The On-Balance Volume (OBV) indicator shows no clear trend weekly and a mildly bearish stance monthly, signalling that volume flows have not decisively supported recent price gains. This lack of volume confirmation could temper enthusiasm among momentum traders.

RSI and Bollinger Bands: Neutral to Mildly Bullish Signals

The Relative Strength Index (RSI) for Lupin shows no clear signal on both weekly and monthly timeframes, indicating neither overbought nor oversold conditions. This neutrality suggests that the stock is not currently stretched in either direction, allowing room for potential upward movement without immediate risk of a sharp correction.

Bollinger Bands provide a slightly more optimistic outlook. On a weekly basis, the bands are mildly bearish, reflecting some recent price volatility and potential resistance near the upper band. Conversely, the monthly Bollinger Bands are mildly bullish, implying that the stock’s longer-term price volatility is contained within an upward trending channel. This mixed reading aligns with the broader technical narrative of cautious optimism.

Moving Averages and Dow Theory: Signs of Emerging Strength

Daily moving averages for Lupin have turned mildly bullish, signalling that short-term price momentum is gaining traction. This is a positive development for traders looking for confirmation of a trend reversal or continuation. The Dow Theory assessment adds further nuance: weekly readings are mildly bearish, but monthly readings are bullish. This suggests that while short-term price action may experience some pullbacks, the medium to long-term trend remains constructive.

Investors should note that the stock’s current Mojo Score stands at 64.0, with a Mojo Grade downgraded from Buy to Hold as of 14 Aug 2026. This adjustment reflects the mixed technical signals and the need for a more cautious stance despite the underlying bullish momentum. The mid-cap classification of Lupin also implies a moderate risk profile relative to large-cap pharmaceutical peers.

Investment Implications and Outlook

Lupin’s technical landscape is characterised by a delicate balance between emerging bullish momentum and lingering short-term caution. The mildly bullish daily moving averages and monthly MACD suggest that the stock could continue to advance, potentially testing resistance near its 52-week high of ₹2,530.00. However, the weekly bearish signals from MACD, KST, and Dow Theory indicate that investors should remain vigilant for possible pullbacks or consolidation phases.

Given the stock’s recent outperformance relative to the Sensex and its strong multi-year returns, Lupin remains an attractive candidate for investors with a medium to long-term horizon. The downgrade to a Hold rating by MarketsMOJO reflects the need to monitor technical developments closely, especially volume trends and momentum indicators, before committing additional capital.

In summary, Lupin Ltd. is navigating a transitional phase in its technical profile. While the broader trend remains constructive, mixed signals from key indicators counsel a measured approach. Investors should weigh Lupin’s solid fundamentals and sector positioning against the current technical nuances to make informed decisions.

Summary of Key Technical Indicators for Lupin Ltd.

• MACD: Weekly - Mildly Bearish; Monthly - Bullish
• RSI: Weekly & Monthly - No Signal
• Bollinger Bands: Weekly - Mildly Bearish; Monthly - Mildly Bullish
• Moving Averages (Daily): Mildly Bullish
• KST: Weekly & Monthly - Mildly Bearish
• Dow Theory: Weekly - Mildly Bearish; Monthly - Bullish
• OBV: Weekly - No Trend; Monthly - Mildly Bearish

Price and Return Highlights

• Current Price: ₹2,259.20
• Day Change: +1.08%
• 52-Week High/Low: ₹2,530.00 / ₹1,881.80
• Returns vs Sensex: 1Y +15.27% vs -3.56%; 3Y +107.04% vs +19.30%; 5Y +131.93% vs +39.32%

Investors should continue to monitor Lupin’s technical indicators alongside fundamental developments in the Pharmaceuticals & Biotechnology sector to capitalise on potential opportunities while managing risk prudently.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →